|
nasdaq:akba
|
5020330
|
Apr 21st, 2024 12:00AM
|
Akebia Therapeutics
|
36K
|
248.00
|
Open
|
|
Apr 20th, 2024 10:48PM
|
Apr 20th, 2024 10:48PM
|
Akebia Therapeutics, Inc. is a growing biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the development and commercialization of therapeutics for people living with kidney disease.
Please review our social media guidelines at: https://akebia.com/social-media-guidelines/
|
Open
|
|
Open
|
245 First Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Akebia Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:akba
|
5020330
|
Apr 20th, 2024 12:00AM
|
Akebia Therapeutics
|
36K
|
248.00
|
Open
|
|
Apr 19th, 2024 10:38PM
|
Apr 20th, 2024 04:30PM
|
Akebia Therapeutics, Inc. is a growing biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the development and commercialization of therapeutics for people living with kidney disease.
Please review our social media guidelines at: https://akebia.com/social-media-guidelines/
|
Open
|
|
Open
|
245 First Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Akebia Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:akba
|
5020330
|
Apr 19th, 2024 12:00AM
|
Akebia Therapeutics
|
36K
|
248.00
|
Open
|
|
Apr 18th, 2024 10:46PM
|
Apr 18th, 2024 10:46PM
|
Akebia Therapeutics, Inc. is a growing biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the development and commercialization of therapeutics for people living with kidney disease.
Please review our social media guidelines at: https://akebia.com/social-media-guidelines/
|
Open
|
|
Open
|
245 First Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Akebia Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:akba
|
5020330
|
Apr 18th, 2024 12:00AM
|
Akebia Therapeutics
|
36K
|
248.00
|
Open
|
|
Apr 17th, 2024 10:48PM
|
Apr 18th, 2024 05:50PM
|
Akebia Therapeutics, Inc. is a growing biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the development and commercialization of therapeutics for people living with kidney disease.
Please review our social media guidelines at: https://akebia.com/social-media-guidelines/
|
Open
|
|
Open
|
245 First Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Akebia Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:akba
|
5020330
|
Apr 17th, 2024 12:00AM
|
Akebia Therapeutics
|
36K
|
243.00
|
Open
|
|
Apr 16th, 2024 10:36PM
|
Apr 17th, 2024 02:14PM
|
Akebia Therapeutics, Inc. is a growing biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the development and commercialization of therapeutics for people living with kidney disease.
Please review our social media guidelines at: https://akebia.com/social-media-guidelines/
|
Open
|
|
Open
|
245 First Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Akebia Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:akba
|
5020330
|
Apr 16th, 2024 12:00AM
|
Akebia Therapeutics
|
36K
|
243.00
|
Open
|
|
Apr 15th, 2024 10:35PM
|
Apr 16th, 2024 10:30AM
|
Akebia Therapeutics, Inc. is a growing biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the development and commercialization of therapeutics for people living with kidney disease.
Please review our social media guidelines at: https://akebia.com/social-media-guidelines/
|
Open
|
|
Open
|
245 First Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Akebia Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:akba
|
5020330
|
Apr 15th, 2024 12:00AM
|
Akebia Therapeutics
|
36K
|
243.00
|
Open
|
|
Apr 14th, 2024 10:37PM
|
Apr 15th, 2024 04:11PM
|
Akebia Therapeutics, Inc. is a growing biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the development and commercialization of therapeutics for people living with kidney disease.
Please review our social media guidelines at: https://akebia.com/social-media-guidelines/
|
Open
|
|
Open
|
245 First Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Akebia Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:akba
|
5020330
|
Apr 14th, 2024 12:00AM
|
Akebia Therapeutics
|
36K
|
244.00
|
Open
|
|
Apr 13th, 2024 10:31PM
|
Apr 13th, 2024 10:31PM
|
Akebia Therapeutics, Inc. is a growing biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the development and commercialization of therapeutics for people living with kidney disease.
Please review our social media guidelines at: https://akebia.com/social-media-guidelines/
|
Open
|
|
Open
|
245 First Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Akebia Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:akba
|
5020330
|
Apr 13th, 2024 12:00AM
|
Akebia Therapeutics
|
36K
|
244.00
|
Open
|
|
Apr 12th, 2024 10:22PM
|
Apr 13th, 2024 10:58AM
|
Akebia Therapeutics, Inc. is a growing biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the development and commercialization of therapeutics for people living with kidney disease.
Please review our social media guidelines at: https://akebia.com/social-media-guidelines/
|
Open
|
|
Open
|
245 First Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Akebia Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:akba
|
5020330
|
Apr 12th, 2024 12:00AM
|
Akebia Therapeutics
|
36K
|
244.00
|
Open
|
|
Apr 11th, 2024 10:25PM
|
Apr 12th, 2024 07:53AM
|
Akebia Therapeutics, Inc. is a growing biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the development and commercialization of therapeutics for people living with kidney disease.
Please review our social media guidelines at: https://akebia.com/social-media-guidelines/
|
Open
|
|
Open
|
245 First Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Akebia Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|